Home
- Eating Well (or at Least Not terribly) at Fast Food Resturants
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
What’s Up With the JDRF and Denise Faustman?
This past April 12, 2005, would have come and gone like any other day had I not seen a headline in my local paper that caught my eye:
“Polio Vaccine’s Golden Anniversary” (San Francisco Chronicle, April 11, 2005).
Yes, April 12, 2005, marked the 50th anniversary of Jonas Salk’s development of the vaccine that cured infantile paralysis, or as we better know it, polio.
As a type 1 for 30 years, it got me thinking: Was polio really the last disease that was actually cured? No disrespect to Dr. Salk—a genius and hero by all accounts—but I would think that the scientists, technology, resources and brain power we have today are much better at developing cures than they were 50 years ago.
But polio is still the last disease that was cured.
So I ask you: What is so hard about finding a cure for type 1 diabetes, or cancer or even the common cold? Could it be, as our October 2003 cover story pointed out, that curing a profitable disease is not a good business decision? That too many companies would stand to lose too much if there were a cure for diabetes, or cancer or the common cold?
Why Did the JDRF Circulate a Letter Critical of Denise Faustman’s Work?
That question leads into our article this month on Denise Faustman’s regenerative research.
As you know, we covered Denise Faustman’s research in the March 2004 issue of Diabetes Health (“The Latest Cure: Injected Spleen Cells Reverse Type 1 in Mice,”). This was a full eight months before The New York Times finally got around to covering it in a November 2004 article. When The Times did, however, the Juvenile Diabetes Research Foundation (JDRF) sent a letter to The Times criticizing Faustman’s work, which The Times did not publish. Afterward, the JDRF circulated the unpublished letter to its chapters in an e-mail, which made its way into the hands of several of our readers.
As previously reported in this magazine, Dr. Faustman has petitioned the JDRF in the past to fund her research, only to be turned down. I am a member of the JDRF and enjoy receiving their quarterly magazine. I realize that it is certainly not our place to question how the JDRF spends its research money, but our readers started asking, Why would the JDRF circulate a letter critical of Dr. Faustman’s work?
We had to investigate.
Read Martin Jensen’s article (“Why Did the JDRF Try to Discredit Cure Research?”) and let us know what you think in the coming months.
As a type 1, I couldn’t be more excited about the FDA’s decision to approve Symlin (pramlintide acetate) injections to be used in conjunction with insulin to treat diabetes.
I’ve been hearing nothing but positive things about this synthetic analog for years now and am excited that type 1s and insulin-using type 2s now have another treatment option. See our article (“FDA Approves Symlin”) to learn more about it.
Scott King
Editor-in-Chief
Type 1, 30 years (and counting)
Please send me your comments and suggestions via e-mail through our Web site.
Categories: Diabetes, Diabetes, Insulin, My Own Injection, Type 1 Issues, Type 2 Issues
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
I believe that the members ot the JDRF have every right to question the attitude of the JDRF towards Dr,Faustman.It raises the question that the JDRF wants the diabetes cure process to progress only under its own terms.
The research of Dr.Faustman is logical,and painstakingly complete in identifying and counting the rogue T cells,and their destruction by TNF alpha activated by BCG vaccine.It is time for the chapters and donors to demand some answers of the JDRF as to why they do not contribute.It is after all the members money.Could there be some picque over the Iacocca million.
Faustman has no other major source of funding.Petitioning the Institutes of Health might help, but a direct application to the President could be more productive.
Hi i want inform you about new project for support Dr Faustman's research.
It's a lobby group created for support Dr faustman's research.
It's a free way to help the research..
To all Dr faustman supporters , you could help speed up the funding of Dr. Faustman's most promising research:
A) to reverse type 1 diabetes
B) at cheap price (generic BCG)
c) with the safest approach (long history of safety use)
How: You can join the lobby group newsletter totally free at http://www.hdiabetes.com
Dr. Denise Faustman just started Phase II Clinical Trials after Phase I proved BCG safety in high doses. Will an expert please explain this for us lay people? Thanks!
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...